Announcements Trials

Browse Landscape

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 2 Other 1 Gynecologic 1 Genitourinary 1

Conditions

Ovarian Neoplasms 406 Uterine Cervical Neoplasms 400 Endometrial Neoplasms 197 Carcinoma, Ovarian Epithelial 100 Breast Neoplasms 72 Fallopian Tube Neoplasms 71 Uterine Cervical Dysplasia 68 Neoplasms 51 Colorectal Neoplasms 42 Pancreatic Neoplasms 40 Stomach Neoplasms 39 Peritoneal Neoplasms 32 Papillomavirus Infections 32 Recurrence 31 Uterine Neoplasms 29 Vulvar Neoplasms 27 Prostatic Neoplasms 26 Lung Neoplasms 24 Esophageal Neoplasms 23 Urinary Bladder Neoplasms 22 Melanoma 20 Colonic Neoplasms 20 Head and Neck Neoplasms 19 Gynecologic Cancer 19 Endometrial Hyperplasia 18 Neoplasm Metastasis 17 Carcinoma, Non-Small-Cell Lung 17 Squamous Intraepithelial Lesions 16 Sarcoma 16 Ovarian Cysts 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Risk Reduction Behavior × Gynecologic × Clear all

NCT04470921 2024-01-26

STOPOVCA

Radboud University Medical Center

10,000 enrolled

Ovarian Neoplasms, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon ⚡